Xylazine is an agonist at kappa opioid receptors and exhibits sex-specific responses to opioid antagonism
Article in Addiction Neuroscience (June 2024)
The most recent citing publications are shown below. View all 110 publications that cite this research output on Dimensions.
Article in Addiction Neuroscience (June 2024)
Article in Neuroscience & Biobehavioral Reviews (May 2024)
Preprint in bioRxiv (May 2024)